KISQALI FEMARA CO-PACK (COPACKAGED) FDA approval date
The FDA approved KISQALI FEMARA CO-PACK (COPACKAGED) on 4 May 2017.
- FDA approval date
- 4 May 2017
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as LETROZOLE; RIBOCICLIB SUCCINATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2017-05-04Day | KISQALI FEMARA CO-PACK (COPACKAGED) | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA209935", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["KISQALI FEMARA CO-PACK (COPACKAGED)"], "active_ingredients": ["LETROZOLE", "RIBOCICLIB SUCCINATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170504", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |